• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Microbiologists and plant scientists find secret to tackling cholera

Bioengineer by Bioengineer
June 25, 2018
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Courtesy of MSU

EAST LANSING, Mich. – While cholera rages across many regions of the world, a team of microbiologists and plant scientists has pinpointed a genetic weakness in the pandemic's armor, which could lead to future treatments.

The current cholera pandemic began in Indonesia in 1961. Rather than fade away like its six previous worldwide outbreak predecessors, the responsible strain is thriving and actually picking up steam. A discovery, led by scientists from Michigan State University and Tufts University and featured in the current issue of PNAS, shows the key genetic change the seventh pandemic acquired to thrive for more than 50 years.

The interdisciplinary team of scientists reveal the first ever signaling network for a new bacterial signal, cyclic GMP-AMP (cGAMP), in the human cholera pathogen. The team also identified the first protein receptor of cGAMP as a phospholipase enzyme that remodels the V. cholerae membrane when cGAMP is produced.

"When this pandemic emerged, it virtually displaced all of the other V. cholerae isolates, or previous strains, on a worldwide scale," said Chris Waters, MSU microbiology professor, who co-led the study with Wai-Leung Ng, Tufts microbiologist. "No one really knows why this happened. Our discovery of cGAMP synthase and phospholipase, which are present only in the seventh pandemic, could be key drivers of the seventh cholera pandemic."

The evolution of this new signaling ability has contributed to this current strain – nicknamed "El Tor" – in causing around 95,000 deaths annually. Just last year in Yemen, more than 1 million people contracted cholera and nearly 2,200 people died, making it one of the largest cholera outbreaks in world history.

Serendipity and interdisciplinary research contributed to this discovery. Even though they were postdoctoral fellows at Princeton University together, Waters and Ng didn't realize they were studying the same genetic pathway until they landed their positions at their respected universities.

Once they began to compare notes, they realized their research had real potential to understand this new cholera pandemic.

Graduate students Geoff Severin in the Waters lab and Miriam Ramliden in the Ng lab led the team to an island – the Vibrio seventh pandemic island – to find cholera's genetic advances that's allowed El Tor to find the traits none of its predecessors possessed. On this atoll of around 20 newly acquired genes was where they found the buried treasure of the phospholipase cGAMP receptor.

Waters knew that Christoph Benning, a renowned plant scientist and director of the MSU-DOE Plant Research Laboratory, was an expert in lipids and would possibly have some leads on the phospholipase – enzymes that degrade membrane building blocks – on which they were focusing.

"I immediately answered that yes we would like to help and that we could contribute to this research," Benning said. "If you break it down to the biochemistry, it doesn't matter if it's a human, bacterium or plant; we have many of the same genes and enzymes."

And indeed they did. Benning enlisted the help of Kenny (Kun) Wang, a former graduate student in his lab. Wang had become an expert on these types of plant proteins, which are tricky to produce as they can destroy cells in the process. He obtained and made the cholera phospholipase work in a test tube so the team could study how it is controlled by cGAMP.

Now that the scientists have unearthed the treasure, they're looking for the keys to unlock one of El Tor's greatest strengths, and turn it against itself.

"We think this new system is one of the key elements that led to the emergence and persistence of the current pandemic," Ng said. "Our future research will try to understand the role that the cGAMP/phospholipase system played in this emergence."

###

This research was funded by the National Institutes of Health (GM007310, AI007329, AI121337, GM109259, GM110444, AI130554, GM109259 and AI125452), the National Science Foundation (MCB-1253684) and the Department of Energy (DE-FG02-98ER20305 and DE-FG02-91ER20021).

Michigan State University has been working to advance the common good in uncommon ways for more than 150 years. One of the top research universities in the world, MSU focuses its vast resources on creating solutions to some of the world's most pressing challenges, while providing life-changing opportunities to a diverse and inclusive academic community through more than 200 programs of study in 17 degree-granting colleges.

For MSU news on the Web, go to MSUToday. Follow MSU News on Twitter at twitter.com/MSUnews.

Media Contact

Layne Cameron
[email protected]
517-353-8819
@MSUnews

http://msutoday.msu.edu/journalists/

Original Source

https://go.msu.edu/vBH

Share12Tweet8Share2ShareShareShare2

Related Posts

Personalized Guide to Understanding and Reducing Chemicals

February 7, 2026

Inflammasome Protein ASC Drives Pancreatic Cancer Metabolism

February 7, 2026

Phage-Antibiotic Combo Beats Resistant Peritoneal Infection

February 7, 2026

Boosting Remote Healthcare: Stepped-Wedge Trial Insights

February 7, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Personalized Guide to Understanding and Reducing Chemicals

Inflammasome Protein ASC Drives Pancreatic Cancer Metabolism

Phage-Antibiotic Combo Beats Resistant Peritoneal Infection

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.